Skip to Content

Join the 'Memantine' group to help and get support from people like you.

Memantine News

Forest and Merz Announce FDA Approval of Namenda XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

Posted 22 Jun 2010 by Drugs.com

NEW YORK--(BUSINESS WIRE)--Jun 21, 2010 - Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that Namenda XR (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. Namenda XR is a 28 mg once-daily extended-release formulation of Namenda. The safety and efficacy of Namenda XR ...

Ask a Question

Further Information

Related Condition Support Groups

Alzheimer's Disease, Migraine, Autism

Related Drug Support Groups

Namenda, Namenda XR

Memantine Patient Information at Drugs.com